Position
Citadel in Compass Therapeutics, Inc.
Back to the book · All holders of CMPX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$2.24M$5.29 → $2.19
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 105.7K | $567.5K | — | — | — | 0.0% |
| Q1 2026 | 721.4K | $3.82M | $5.29 | −$8.45K | $3.26M | 0.0% |
| Q2 2026 | 3.57M | $7.82M | $2.19 | −$2.24M | $6.24M | 0.0% |